Medibank shares remain in limbo after customer data hack confirmed

Hackers claim to have taken 200GB of customer data from Medibank…

| More on:
A man sits in casual clothes in front of a computer amid graphic images of data superimposed on the image, as though he is engaged in IT or hacking activities.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Medibank Private Ltd (ASX: MPL) shares won't be going anywhere today.

This afternoon, Australia's largest private health insurance provider released another update on its cyber incident.

Unfortunately, things have continued to get worse for Medibank and it has requested that it shares remain halted until the matter is resolved.

What's going on?

As readers may be aware, last week Medibank revealed that it had detected unusual activity on its network. At the time it didn't believe that customer data had been taken from its systems.

However, last night the company advised that it had received messages from a group claiming to have removed customer data and wanting to negotiate a ransom for it.

This afternoon, Medibank revealed that this group has claimed to have taken 200GB of customer data from its systems.

As proof, the group has provided a sample of the data to Medibank. That data includes names, addresses, dates of birth, Medicare numbers, policy numbers, phone numbers, and some claims data. The latter includes the location of where a customer received medical services, and codes relating to their diagnosis and procedures.

Other data that the group claims to have taken includes data related to credit card security. Though, this has not been confirmed by its investigations.

However, given that Medibank's team (worryingly) couldn't even tell that 200GB of data had been taken from its systems last week, it may be prudent to assume that what the group is saying is accurate about credit card data.

Given the nature of the information that has been taken, Medibank advised that it is in discussions with government stakeholders about what it can do to assist its customers in safeguarding their identities and health information.

Medibank's CEO, David Koczkar, added:

I unreservedly apologise for this crime which has been perpetrated against our customers, our people, and the broader community. I know that many will be disappointed with Medibank and I acknowledge that disappointment.

This cybercrime is now the subject of an investigation by the Australian Federal Police. We will learn from this incident and will share our learnings with others. Medibank will remain open and transparent and will continue to provide comprehensive updates as often as we can and need to.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

medical doctor performing surgery using surgical instruments
Healthcare Shares

Biotech company implants heart device in world first

This biotech company has implanted a heart device as part of a clinical trial looking to open up new markets.

Read more »

Person pressing the buy button on a smartphone.
Healthcare Shares

Why this buy rated ASX 200 healthcare share is tipped to surge 52%

A leading investment expert forecasts a big rebound for this $8 billion ASX healthcare share.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on big news

This stock is getting a lot of attention from investors on Wednesday. But why?

Read more »

Four smiling young medics with arms crossed stand outside a hospital.
Healthcare Shares

How much further upside is there for Mesoblast shares after soaring 23% in a month?

Could FDA approval send this healthcare stock towards further gains?

Read more »

woman in lab coat conducting testing representing biotech
Healthcare Shares

Is this soaring ASX 200 healthcare share just getting started?

If its lead therapy gets US approval, the stock can continue to climb.

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Broker Notes

Macquarie forecasts this $3.4 billon ASX healthcare share is set surge 33%

Macquarie tips material outperformance from this ASX healthcare share in 2026.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Own CSL shares? Here are the key dates for 2026

It's been a bad year for CSL shares. What's ahead in 2026?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »